Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

Featured Releases

December 09, 2025 21:51 ET | Source: Faraday Future

Faraday Future Begins Production of the First FX Super One Pre-Production Vehicles at Its Hanford Facility, Nears Completion of the Bridge Closure for the Company’s Global Automotive Industry Bridge Strategy

This production start follows the recent arrival of multiple full sets of knockdown components — nearly 3,000 parts per vehicle — required for building the first batch of complete pre-production FX...
Read More
December 09, 2025 20:15 ET | Source: Fiesta Productions

The Birth of a Creative Powerhouse

IRWINDALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- The 137th Rose Parade® will feature some familiar “faces” and welcome a number of new ones when communities, companies and organizations once...
Read More

December 10, 2025 01:00 ET | Source: Aegon Ltd.

Aegon Capital Markets Day 2025 – The Next Frontier

Strategic highlights: Aegon announces ambition to become a leading US life insurance and retirement group Aegon to move its head office and legal seat to the US and be renamed Transamerica Inc. at...
December 10, 2025 01:00 ET | Source: Coop Pank AS

Coop Pank AS results for November 2025

Coop Pank’s financial results in November 2025: In November, the number of the bank’s customers increased by 1,800 and number of active customers increased by 1,000. By the end of the month number of...
December 10, 2025 01:00 ET | Source: GlobeNewswire, Inc.

Start of Day Message

LONDON, 10 Dec. 2025 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
December 10, 2025 01:00 ET | Source: Idorsia Pharmaceuticals Ltd

New Hypertension publication underscores aprocitentan’s potential in managing hypertension patients with CKD

New analysis from landmark Phase 3 PRECISION trial published in Hypertension highlights the renal-protective benefits of aprocitentan in addition to the marked reduction in blood pressure in a...
December 10, 2025 01:00 ET | Source: Hexagon Purus ASA

Amendment to battery cell supply agreement

(10 December 2025 – Oslo, Norway) Reference is made to the stock exchange release by Hexagon Purus (“the “Company”) on 18 April 2023 and 25 October 2024, where Hexagon Purus Systems USA LLC, a...
December 10, 2025 00:14 ET | Source: Denali Therapeutics Inc.

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its...
December 09, 2025 23:35 ET | Source: Canacol Energy Ltd.

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing

CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad...
December 09, 2025 23:30 ET | Source: Terns Pharmaceuticals, Inc.

Terns Announces Pricing of Upsized $650 Million Public Offering

FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its...
December 09, 2025 23:30 ET | Source: Kymera Therapeutics, Inc.

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...
December 09, 2025 23:15 ET | Source: Structure Therapeutics Inc.

Structure Therapeutics Announces Pricing of Upsized $650 Million Public Offering of ADSs and Pre-Funded Warrants

SAN FRANCISCO, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for...

1 2 ...314556